BMRN – BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

BMRN

$56.19

Name : BioMarin Pharmaceutical Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $10,775,892,992.00

EPSttm : 2.7

BioMarin Pharmaceutical Inc.

$56.19

2.22%

$1.22

Float Short %

2.34

Margin Of Safety %

Put/Call OI Ratio

0.64

EPS Next Q Diff

0.09

EPS Last/This Y

2.06

EPS This/Next Y

1.09

Price

56.19

Target Price

96.81

Analyst Recom

1.52

Performance Q

-20.51

Relative Volume

1.34

Beta

0.17

Ticker: BMRN

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-06-02	BMRN	57.04	0.82	0.23	33308
2025-06-03	BMRN	56.78	0.81	0.25	33731
2025-06-04	BMRN	56.1	0.79	0.11	34419
2025-06-05	BMRN	55.18	0.77	0.16	34697
2025-06-06	BMRN	56.64	0.74	0.17	34696
2025-06-09	BMRN	56.85	0.74	0.04	34999
2025-06-10	BMRN	57.48	0.71	0.23	35548
2025-06-11	BMRN	57.14	0.71	0.13	35772
2025-06-12	BMRN	57.22	0.70	0.38	35843
2025-06-13	BMRN	56.16	0.70	0.12	36044
2025-06-16	BMRN	56.23	0.68	0.04	36446
2025-06-17	BMRN	55.04	0.67	0.51	36952
2025-06-18	BMRN	55.22	0.67	0.34	38328
2025-06-20	BMRN	55	0.65	0.29	38696
2025-06-23	BMRN	54.11	0.70	0.37	35863
2025-06-24	BMRN	54.71	0.69	0.89	36389
2025-06-25	BMRN	54.15	0.67	0.10	36404
2025-06-26	BMRN	54.08	0.65	0.36	36290
2025-06-27	BMRN	55.18	0.64	0.38	36164
2025-06-30	BMRN	54.98	0.64	0.60	36228
2025-07-01	BMRN	56.2	0.64	0.50	37349
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-06-02	BMRN	57.04	7.0	-2.0	4.31
2025-06-03	BMRN	56.79	7.0	7.7	4.31
2025-06-04	BMRN	56.07	7.0	1.7	4.31
2025-06-05	BMRN	55.27	7.0	0.0	4.31
2025-06-06	BMRN	56.66	7.0	30.0	4.31
2025-06-09	BMRN	56.88	7.0	14.2	4.31
2025-06-10	BMRN	57.51	7.0	19.4	4.31
2025-06-11	BMRN	57.13	7.0	6.6	4.31
2025-06-12	BMRN	57.28	7.0	12.7	4.31
2025-06-13	BMRN	56.25	7.0	-2.2	4.31
2025-06-16	BMRN	56.24	7.0	11.4	4.31
2025-06-17	BMRN	54.98	7.0	-5.5	4.31
2025-06-18	BMRN	55.24	7.0	14.4	4.31
2025-06-20	BMRN	55.00	7.0	7.9	4.31
2025-06-23	BMRN	54.10	7.0	-0.7	4.31
2025-06-24	BMRN	54.69	7.0	19.6	4.31
2025-06-25	BMRN	54.13	7.0	3.5	4.31
2025-06-26	BMRN	54.10	7.0	10.8	4.31
2025-06-27	BMRN	55.18	7.0	26.1	4.31
2025-06-30	BMRN	54.96	7.0	8.1	4.31
2025-07-01	BMRN	56.19	7.0	27.6	4.31
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-06-02	BMRN	-0.43	0.77	2.35
2025-06-03	BMRN	-0.43	0.77	2.35
2025-06-04	BMRN	-0.43	0.77	2.35
2025-06-05	BMRN	-0.43	0.77	2.35
2025-06-06	BMRN	-0.43	0.77	2.35
2025-06-09	BMRN	-0.43	0.89	2.35
2025-06-10	BMRN	-0.43	0.89	2.35
2025-06-11	BMRN	-0.43	0.89	2.20
2025-06-12	BMRN	-0.43	0.89	2.20
2025-06-13	BMRN	-0.43	0.89	2.20
2025-06-16	BMRN	-0.43	1.88	2.20
2025-06-18	BMRN	-0.43	1.88	2.20
2025-06-20	BMRN	-0.43	1.88	2.20
2025-06-23	BMRN	-0.43	0.95	2.20
2025-06-24	BMRN	-0.43	0.95	2.20
2025-06-25	BMRN	-0.43	0.95	2.20
2025-06-26	BMRN	-0.43	0.95	2.34
2025-06-27	BMRN	-0.43	0.95	2.34
2025-06-30	BMRN	-0.43	0.96	2.34
2025-07-01	BMRN	-0.43	0.96	2.34
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.95

Avg. EPS Est. Current Quarter

1.03

Avg. EPS Est. Next Quarter

1.04

Insider Transactions

-0.43

Institutional Transactions

0.96

Beta

0.17

Average Sales Estimate Current Quarter

761

Average Sales Estimate Next Quarter

798

Fair Value

81.36

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

57.4

Max Drawdown 5-Year %

-58.7

Target Price

96.81

P/E

20.85

Forward P/E

13.44

PEG

0.63

P/S

3.69

P/B

1.86

P/Free Cash Flow

17.26

EPS

2.69

Average EPS Est. Cur. Y

4.31

EPS Next Y. (Est.)

5.4

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

17.93

Relative Volume

1.34

Return on Equity vs Sector %

-14.8

Return on Equity vs Industry %

4.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

27.6

BioMarin Pharmaceutical Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 3040

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company's products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; VOXZOGO, a once daily injection analog of c-type natriuretic peptide (CNP) for the treatment of achondroplasia; NAGLAZYME, a recombinant form of N- acetylgalactosamine 4-sulfatase for patients with MPS VI; and PALYNZIQ, a PEGylated recombinant phenylalanine (Phe) ammonia lyase enzyme delivered through subcutaneous injection to reduce blood Phe concentrations. It also develops BRINEURA, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; ALDURAZYME, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase; KUVAN, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria, an inherited metabolic disease; and ROCTAVIAN, an adeno associated virus vector for the treatment of severe hemophilia A. The company's products under development include BMN 333, a longer-acting CNP for the treatment of multiple growth disorders, such as achondroplasia and hypochondroplasia; BMN 349, an oral therapeutic for the treatment of liver disease associated with alpha-1 antitrypsin deficiency; and BMN 351, an oligonucleotide for the treatment of duchenne muscular dystrophy. It serves specialty pharmacies, hospitals, non-U.S. government agencies, distributors, and pharmaceutical wholesalers. The company has license and collaboration agreements with Catalyst Pharmaceutical Partners, Inc., and Ares Trading S.A. The company was incorporated in 1996 and is based in San Rafael, California.

stock quote shares BMRN – BioMarin Pharmaceutical Inc. Stock Price stock today

news today BMRN – BioMarin Pharmaceutical Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch BMRN – BioMarin Pharmaceutical Inc. yahoo finance google finance

stock history BMRN – BioMarin Pharmaceutical Inc. invest stock market

stock prices BMRN premarket after hours

ticker BMRN fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

BMRN – BioMarin Pharmaceutical Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: BMRN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y